Global Financial Private Client, LLC Moderna, Inc. Transaction History
Global Financial Private Client, LLC
- $239 Billion
- Q2 2024
A detailed history of Global Financial Private Client, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 223 shares of MRNA stock, worth $17,730. This represents 0.01% of its overall portfolio holdings.
Number of Shares
223
Previous 280
20.36%
Holding current value
$17,730
Previous $29.6 Million
10.44%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding MRNA
# of Institutions
1,112Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$3.45 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$3.15 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$2.03 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$1.19 Billion0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$575 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $31.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...